https://www.spreaker.com/podcast/evolution-and-innovation-in-oncology-therapeutics-development--5674571enMedicineCopyright Industry Dive's studioIDhttps://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/12e93a1fcae32f5857980b6de6a88c1d.jpghttps://www.spreaker.com/podcast/evolution-and-innovation-in-oncology-therapeutics-development--5674571Thu, 29 Feb 2024 20:34:21 +0000Industry Dive's studioIDIndustry Dive's studioIDfeeds@spreaker.comThis podcast will feature host Dr. Stephen Gately, PhD, President & CEO of TD2, as he discusses the complex challenges of drug development and innovative technologies in a new podcast series dedicated to the evolution of oncology therapeuticsfalseepisodichttps://www.spreaker.com/episode/the-importance-of-metabolic-and-proteomic-analyses-in-identifying-treatment-pathways-for-cancer-patients--56725952https://api.spreaker.com/episode/56725952Mon, 11 Sep 2023 13:00:02 +0000Industry Dive's studioIDListen in as the CEO of TD2, Dr. Stephen Gately, sits down with Dr. Ed Weinstein, co-founder and CEO of Panome Bio, to discuss their important research on metabolomics and proteomics. Gain insights into new screening technology for important metabolic...2592cancer,oncologyfalse2fullhttps://www.spreaker.com/episode/biomarkers-and-the-utility-of-proteomics-for-dose-optimization-and-confirmation-of-target-engagement--51390318https://api.spreaker.com/episode/51390318Fri, 30 Sep 2022 13:00:02 +0000Industry Dive's studioIDIn this inaugural episode, Dr. Gately sits down with Dr. Emanuel “Chip” Petricoin, professor at George Mason University in the School of Systems Biology, Co-Director of the Center for Applied Proteomics and Molecular Medicine and founder and chairman...2497cancer,cancertreatment,clinicaltrials,genomicanalyses,immunotherapy,nextgenerationsequencing,oncology,oncologytherapeutics,proteomicanalyses,proteomics,reversephaseproteinarray,tumortreatmentfalsefull